INHIBITION OF GRANULOCYTE DIFFERENTIATION BY G(1) CYCLINS D2 AND D3 BUT NOT D1

被引:239
|
作者
KATO, JY
SHERR, CJ
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT TUMOR CELL BIOL, 332 N LAUDERDALE, MEMPHIS, TN 38101 USA
[2] ST JUDE CHILDRENS RES HOSP, HOWARD HUGHES MED INST, MEMPHIS, TN 38101 USA
关键词
D-TYPE CYCLINS; CYCLIN-DEPENDENT KINASES; G(1) PROGRESSION;
D O I
10.1073/pnas.90.24.11513
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Growth factor-induced signals govern the expression of three D-type cyclins, which, in turn, function as regulatory subunits of cyclin-dependent kinases (cdks) to control cell cycle transitions during the late G1 interval. 32D myeloid cells, which self-renew as uncommitted precursors in interleukin 3 (IL-3), express cyclins D2 and D3 (but not D1) in complexes with cdk4 and cdk2. When transferred to granulocyte colony-stimulating factor (G-CSF), 32D cells stop dividing and terminally differentiate to mature neutrophils. Cyclin D and cdk4 expression ceased as cells underwent growth arrest in G-CSF, but cdk2 levels were sustained. 32D cells engineered to ectopically express D-type cyclins exhibited contracted G1 intervals with a compensatory lengthening of S phase but remained IL-3 dependent for cell growth; those overexpressing cyclins D2 and D3 (but not D1) were unable to differentiate and died in G-CSF. Cyclin D2 mutants, which cannot efficiently bind to, or functionally interact with, the retinoblastoma protein (pRb) or its relatives (p107) did not block differentiation. Conversely, the introduction of a catalytically inactive cdk4 mutant into cells overexpressing cyclin D2 restored their G-CSF response. The persistence of cdk2 and its predilection to functionally interact with cyclins D2 and D3 rather than D1 might explain the specificity of the differentiation blockade.
引用
收藏
页码:11513 / 11517
页数:5
相关论文
共 50 条
  • [1] INHIBITION OF GRANULOCYTE DIFFERENTIATION BY G1 CYCLINS, D2 AND D3, BUT NOT D1
    KATO, JY
    SHERR, CJ
    [J]. BLOOD, 1993, 82 (10) : A182 - A182
  • [2] D-TYPE CYCLINS (D1, D2, AND D3)
    不详
    [J]. HYBRIDOMA, 1994, 13 (01): : 79 - 79
  • [3] D1 AND D2 AND D3
    HEALY, D
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 : 319 - 324
  • [4] Expression of cyclins D1, D2 and D3 and Ki-67 in human leukemia
    Jaroslav, P
    Martina, H
    Jirí, S
    Hana, K
    Petr, S
    Tomás, K
    Julius, M
    Cedrik, H
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1605 - 1612
  • [5] Role of cyclins D1 and D3 in vestibular schwannoma
    Jabbour, J.
    Earls, P.
    Biggs, N.
    Gracie, G.
    Fagan, P.
    Bova, R.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 : S2 - S10
  • [6] Differential regulation of cyclins D1 and D3 in hepatocyte proliferation
    Rickheim, DG
    Nelsen, CJ
    Fassett, JT
    Timchenko, NA
    Hansen, LK
    Albrecht, JH
    [J]. HEPATOLOGY, 2002, 36 (01) : 30 - 38
  • [7] Cyclins D1, D3, E, and A in vulvar carcinoma patients
    Knopp, S
    Bjorge, T
    Nesland, JM
    Tropé, C
    Holm, R
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 733 - 739
  • [8] Expression of cyclins d1, d2, and d3 in chronic lymphocytic Leukemia/Small lymphocytic lymphoma (CLL/SLL)
    Chen, W.
    Rassidakis, G. Z.
    Leventaki, V.
    Abruzzo, L. V.
    Bueso-Ramos, C. E.
    McKenna, R. W.
    Medeiros, I. J.
    [J]. LABORATORY INVESTIGATION, 2007, 87 : 236A - 237A
  • [9] Expression of cyclins D1, D2, and D3 in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Chen, W.
    Rassidakis, G. Z.
    Leventaki, V.
    Abruzzo, L. V.
    Bueso-Ramos, C. E.
    McKenna, R. W.
    Medeiros, L. J.
    [J]. MODERN PATHOLOGY, 2007, 20 : 236A - 237A
  • [10] Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1
    Lahti, JM
    Li, HM
    Kidd, VJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (16) : 10859 - 10869